Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: A multivariate analysis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Bruns, Helge ^a   Lozanovski, Vladimir J ^a   Schultze, Daniel ^a   Hillebrand, Norbert ^a   Hinz, Ulf ^a   Büchler, Markus W ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; SODIUM;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; D MELD SCORE; DONOR RISK INDEX; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; LABMELD SCORE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIVARIATE ANALYSIS; NAMELD SCORE; PREDICTION; RETRANSPLANTATION; SCORING SYSTEM; SEX DIFFERENCE; SURGICAL MORTALITY; SURVIVAL RATE; BIOSTATISTICS; MIDDLE AGED; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RESOURCE ALLOCATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SURVIVAL;

BIOSTATISTICS; FEMALE; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RESOURCE ALLOCATION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84902590292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098782     Document Type: Article

References (62)

1. Merion RM (2010) Current status and future of liver transplantation. Semin Liver Dis 30: 411-421.
2. Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP (1981) Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med 305: 266-269. (Pubitemid 11087372)
3. Jenkins RL, Fairchild RB (1989) The role of transplantation in liver disease. Surg Clin North Am 69: 371-382. (Pubitemid 19092642)
4. Schmied BM, Mehrabi A, Schallert C, Schemmer P, Sauer P, et al. (2005) Evolution of liver transplantation at the University of Heidelberg: interventions influencing patient referral. Transplantation 80: S147-150. (Pubitemid 41552927)
5. Desschans B, Van Gelder F, Van Hees D, de Rocy J, Monbaliu D, et al. (2008) Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts. Acta Chir Belg 108: 31-34.
6. Weismuller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, et al. (2011) Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - limitations of the 'sickest first'-concept. Transpl Int 24: 91-99.
7. Kim HJ, Larson JJ, Lim YS, Kim WR, Pedersen RA, et al. (2010) Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant 10: 2652-2657.
8. Quante M, Benckert C, Thelen A, Jonas S (2012) Experience Since MELD Implementation: How Does the New System Deliver? Int J Hepatol 2012: 264015.
9. Bruns H, Hillebrand N, Schneider T, Hinz U, Fischer L, et al. (2011) LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 25: E558-565.
10. Benckert C, Quante M, Thelen A, Bartels M, Laudi S, et al. (2011) Impact of the MELD allocation after its implementation in liver transplantation. Scand J Gastroenterol 46: 941-948.
11. Tsui TY, Scherer MN, Schnitzbauer AA, Schlitt HJ, Obed A (2009) Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality. Langenbecks Arch Surg 394: 235-241.
12. David AI, Coelho MP, Paes AT, Leite AK, Della Guardia B, et al. (2012) Liver transplant outcome: a comparison between high and low MELD score recipients. Einstein (Sao Paulo) 10: 57-61.
13. Schmidt J, Muller SA, Mehrabi A, Schemmer P, Buchler MW (2008) Orthotopic liver transplantation. Techniques and results. Chirurg 79: 112-120.
14. Venettoni S, Scalamogna M, Curtoni ES, Adorno D, Marino IR, et al. (2004) Transplant quality in Italy: analysis of the 1995-2000 period. Transpl Int 17: 402-415. (Pubitemid 39362568)
15. Weiss KH, Gotthardt D, Schmidt J, Schemmer P, Encke J, et al. (2007) Liver transplantation for metabolic liver diseases in adults: indications and outcome. Nephrol Dial Transplant 22 Suppl 8: viii9-viii12.
16. Afonso RC, Hidalgo R, Paes AT, Zurstrassen MP, Fonseca LE, et al. (2008) Impact of cumulative risk factors for expanded criteria donors on early survival after liver transplantation. Transplant Proc 40: 800-801. (Pubitemid 351608686)
17. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, et al. (2006) Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 6: 791-796. (Pubitemid 43345018)
18. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD (2009) DMELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 9: 318-326.
19. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, et al. (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6: 783-790. (Pubitemid 43345017)
20. Schrem H, Reichert B, Fruhauf N, Becker T, Lehner F, et al. (2012) The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity. Ann Transplant 17: 5-13.
21. Togashi J, Sugawara Y, Akamatsu N, Tamura S, Yamashiki N, et al. (2013) Quality of life after adult living donor liver transplantation: A longitudinal prospective follow-up study. Hepatol Res.
22. Wheeler MD, Ikejema K, Enomoto N, Stacklewitz RF, Seabra V, et al. (1999) Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci 56: 843-856.
23. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91-96. (Pubitemid 36055342)
24. Mieth M, Schemmer P, Encke J, Weigand M, Weitz J, et al. (2006) Heidelberger Manual der Lebertransplantation.
25. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470. (Pubitemid 32119037)
26. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, et al. (2008) Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359: 1018-1026.
27. Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl 2: S54-64. (Pubitemid 32844113)
28. Rossi E (1997) Cardiovascular disease in diabetes and operative risk. Rays 22: 595-602.
29. Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, et al. (2012) GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis 59: 829-840.
30. Avolio AW, Siciliano M, Barbarino R, Nure E, Annicchiarico BE, et al. (2008) Donor risk index and organ patient index as predictors of graft survival after liver transplantation. Transplant Proc 40: 1899-1902.
31. Bonney GK, Aldersley MA, Asthana S, Toogood GJ, Pollard SG, et al. (2009) Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation 87: 1858-1863.
32. Buenadicha AL, Martin LG, Martin EE, Pajares A, Perez AM, et al. (2005) Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease. Transplant Proc 37: 3881-3883. (Pubitemid 43015199)
33. Edwards E, Harper A (2004) Does MELD work for relisted candidates? Liver Transpl 10: S10-16. (Pubitemid 39406096)
34. Boin IF, Leonardi MI, Luzo AC, Cardoso AR, Caruy CA, et al. (2008) Intraoperative massive transfusion decreases survival after liver transplantation. Transplant Proc 40: 789-791. (Pubitemid 351608660)
35. Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, et al. (2010) Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl 16: 1242-1248.
36. Rahimi RS, Rockey DC (2013) End-stage liver disease complications. Curr Opin Gastroenterol.
37. Garg A, Armstrong WF (2013) Echocardiography in liver transplant candidates. JACC Cardiovasc Imaging 6: 105-119.
38. Filippone EJ, Foy A (2012) The J-curve revisited: a therapeutic dilemma. Cardiol Rev 20: 253-258.
39. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, et al. (1995) The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 59: 859-864.
40. Turner TB, Bennett VL, Hernandez H (1981) The beneficial side of moderate alcohol use. Johns Hopkins Med J 148: 53-63. (Pubitemid 11136460)
41. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, et al. (1996) Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61: 1180-1188. (Pubitemid 26134767)
42. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, et al. (1996) Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 2: 426-430. (Pubitemid 26386861)
43. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, et al. (2006) Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 98: 178-181. (Pubitemid 43975507)
44. Carbo J, Garcia-Samaniego J, Castellano G, Iniguez A, Solis-Herruzo JA (1998) Liver cirrhosis and mortality by abdominal surgery. A study of risk factors. Rev Esp Enferm Dig 90: 105-112. (Pubitemid 128527979)
45. Porte RJ (1993) Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Hemost 19: 191-196.
46. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, et al. (1990) A hypercoagulable state follows orthotopic liver transplantation. Hepatology 12: 553-558. (Pubitemid 20382023)
47. Porte RJ, Ploeg RJ, Hansen B, van Bockel JH, Thorogood J, et al. (1998) Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 11 Suppl 1: S164-167. (Pubitemid 128683533)
48. Zhai Y, Busuttil RW, Kupiec-Weglinski JW (2011) Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 11: 1563-1569.
49. Gastaca M (2012) Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors. Transplant Proc 44: 1545-1549.
50. Scotte M, Dousset B, Calmus Y, Conti F, Houssin D, et al. (1994) The influence of cold ischemia time on biliary complications following liver transplantation. J Hepatol 21: 340-346. (Pubitemid 24308756)
51. Piratvisuth T, Tredger JM, Hayllar KA, Williams R (1995) Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1: 296-301.
52. Totsuka E, Fung JJ, Lee MC, Ishii T, Umehara M, et al. (2002) Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today 32: 792-799. (Pubitemid 35013696)
53. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, et al. (1995) Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60: 790-794.
54. Bruns H, Watanpour I, Gebhard MM, Flechtenmacher C, Galli U, et al. (2011) Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study. Microcirculation 18: 205-213.
55. Brooks BK, Levy MF, Jennings LW, Abbasoglu O, Vodapally M, et al. (1996) Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 62: 1784-1787. (Pubitemid 27014538)
56. Kahn D, Gavaler JS, Makowka L, van Thiel DH (1993) Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 38: 1485-1488. (Pubitemid 23266630)
57. Kahn D, Zeng QH, Makowka L, Murase N, Nakajima Y, et al. (1989) Orthotopic liver transplantation and the cytosolic estrogen-androgen receptor status of the liver: the influence of the sex of the donor. Hepatology 10: 861-866. (Pubitemid 19270175)
58. Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J, et al. (1995) Effect of donor age and sex on the outcome of liver transplantation. Hepatology 22: 1754-1762.
59. Jin B, Liu CZ, Hu SY, Wang TT, Wang L, et al. (2008) Influence of estrogen and androgen on the outcome of liver transplantation. Hepatogastroenterology 55: 207-211. (Pubitemid 351462192)
60. Avolio AW, Agnes S, Magalini SC, Foco M, Castagneto M (1991) Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome. Transplant Proc 23: 2451-2452.
61. Kaseje N, Luthold S, Mentha G, Toso C, Belli D, et al. (2013) Donor hypernatremia influences outcomes following pediatric liver transplantation. Eur J Pediatr Surg 23: 8-13.
62. Cywinski JB, Mascha E, Miller C, Eghtesad B, Nakagawa S, et al. (2008) Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl 14: 59-65. (Pubitemid 351167990)